Biologics targeting IL-17 and IL-23 maintain stability in patients with psoriasis during COVID-19 infection: a case-control study

BACKGROUND: Psoriasis is a chronic and refractory skin disease. The emergence of biologics provides more options for the treatment of psoriasis, but the COVID-19 pandemic poses challenges for the management of psoriasis. OBJECTIVES: The purpose of this study was to investigate the effect of differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Dawei, Yu, Yingyuan, Lu, Jiajing, Tan, Fei, Shi, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657819/
https://www.ncbi.nlm.nih.gov/pubmed/38020100
http://dx.doi.org/10.3389/fmed.2023.1280965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657819/
https://www.ncbi.nlm.nih.gov/pubmed/38020100
http://dx.doi.org/10.3389/fmed.2023.1280965

Ejemplares similares